Lack of KLF4 and p21 expression has been associated with an accumulation of aggressive features in neuroendocrine lung tumors, and KLF4 is presented because of an aggressive phenotype in early-stage breast tumors [42, 43]. The gene discussed is KLF4; the disease is lung neuroendocrine neoplasm.